临床和实验医学杂志2024,Vol.23Issue(15) :1634-1637.DOI:10.3969/j.issn.1671-4695.2024.15.018

血清miR-384、PTBP3水平与妊娠期高血压疾病患者不良妊娠结局的关系

Relationship between serum miR-384 and PTBP3 levels and adverse pregnancy outcomes in patients with hypertensive disorder compli-cating pregnancy

李格琳 臧密密 付雪莲 王丽丽 苗艳
临床和实验医学杂志2024,Vol.23Issue(15) :1634-1637.DOI:10.3969/j.issn.1671-4695.2024.15.018

血清miR-384、PTBP3水平与妊娠期高血压疾病患者不良妊娠结局的关系

Relationship between serum miR-384 and PTBP3 levels and adverse pregnancy outcomes in patients with hypertensive disorder compli-cating pregnancy

李格琳 1臧密密 1付雪莲 1王丽丽 1苗艳1
扫码查看

作者信息

  • 1. 沧州市人民医院产科 河北 沧州 061000
  • 折叠

摘要

目的 检测妊娠期高血压疾病(HDCP)患者血清微RNA(miR)-384、多聚嘧啶区结合蛋白3(PTBP3)表达水平,研究miR-384、PTBP3与患者不良妊娠结局的关系.方法 回顾性选取2020年7月至2021年7月沧州市人民医院收治的100例HDCP患者作为观察组,另选取同期本院的健康孕妇50名作为对照组.根据观察组患者妊娠结局情况分为妊娠结局不良组(n=47),妊娠结局良好组(n=53).比较各组临床资料,检测对比各组血清miR-384、PTBP3水平.采用Pearson相关性分析法分析受试者血清miR-384、PTBP3表达水平相关性;采用受试者操作特征(ROC)曲线评估二者对HDCP患者不良妊娠结局的预测价值;采用多因素Logistic回归分析对患者不良妊娠结局的影响因素进行分析.结果 妊娠结局不良组的收缩压和舒张压分别为(162.34±14.95)、(108.11±10.01)mmHg,均高于妊娠结局良好组[(138.78±13.11)、(99.35±6.03)mmHg]和对照组[(115.25±10.22)、(73.56±4.66)mmHg],差异均有统计学意义(P<0.05).妊娠结局不良组miR-384水平为1.56±0.14,高于妊娠结局良好组(1.23±0.11)和对照组(1.01±0.15),差异均有统计学意义(P<0.05).妊娠结局不良组PTBP3水平为(0.67±0.23)ng/mL,低于妊娠结局良好组[(1.21±0.33)ng/mL]和对照组[(1.53±0.45)ng/mL],差异均有统计学意义(P<0.05).Pearson相关性分析结果显示,观察组患者血清miR-384、PTBP3表达呈负相关(r=-0.472,P=0.001).血清miR-384、PTBP3联合预测患者发生不良妊娠结局的曲线下面积(AUC)大于血清miR-384、PTBP3单独预测的AUC(P<0.05).患者血清miR-384高表达是患者发生不良妊娠结局的危险因素,PTBP3高表达是患者发生不良妊娠结局的保护因素(P<0.05).结论 HDCP患者血清miR-384表达升高,PTBP3表达降低,二者均与患者发生不良妊娠结局有关.

Abstract

Objective To detect the expression levels of serum microRNA(miR)-384 and polypyrimidine tract binding protein 3(PT-BP3)in patients with hypertensive disorder complicating pregnancy(HDCP),and to explore their relationship with adverse pregnancy outcomes.Methods A total of 100 HDCP patients admitted to Cangzhou People's Hospital from July 2020 to July 2021 were prospectively selected as the ob-servation group,and another 50 healthy pregnant women who came to our hospital for physical examination during the same period were selected as the control group.According to the pregnancy outcome of the patients in the observation group,they were divided into the poor pregnancy outcome group(n=47)and the good pregnancy outcome group(n=53).The clinical data of each group were compared,and serum miR-384 and PT-BP3 levels were tested and compared in each group.The correlation between serum miR-384 and PTBP3 expression levels in subjects was ana-lyzed using Pearson correlation analysis.The predictive value of both on adverse pregnancy outcomes in patients with HDCP was analyzed using re-ceiver operating characteristic(ROC)curve.The influencing factors of adverse pregnancy outcomes in patients with HDCP was analyzed using multivariate Logistic regression analysis.Results The systolic and diastolic blood pressure in the poor pregnancy outcome group were(162.34±14.95),(108.11±10.01)mmHg,respectively,which were higher than those in the good pregnancy outcome group[(138.78±13.11),(99.35±6.03)mmHg]and the control group[(115.25±10.22),(73.56±4.66)mmHg],and the differences were statistically significant(P<0.05).The level of miR-384 in the poor pregnancy outcome group was 1.56±0.14,which was higher than that in the good pregnancy outcome group(1.23±0.11)and the control group(1.01±0.15),and the differences were statistically significant(P<0.05).The PTBP3 level in the poor pregnancy outcome group was(0.67±0.23)ng/mL,which was lower than that in the good pregnancy outcome group[(1.21±0.33)ng/mL]and the control group[(1.53±0.45)ng/mL],and the differences were statistically significant(P<0.05).The results of Pearson correlation analysis showed that the expressions of serum miR-384 and PTBP3 in the observation group were negatively correlated(r=-0.472,P=0.001).The results of ROC curve analysis showed that the area under the curve(AUC)of serum miR-384 combined PTBP3 to predict adverse pregnancy outcomes was greater than the AUC predicted by serum miR-384,PTBP3 alone(P<0.05).High serum miR-384 expression in patients is a risk factor for adverse pregnancy outcomes in patients,and high PTBP3 expression is a protective factor for adverse preg-nancy outcomes in patients(P<0.05).Conclusion Serum miR-384 expression is up-regulated and PTBP3 expression is down-regulated in patients with HDCP,both are risk factors for adverse pregnancy outcomes in patients.

关键词

微RNAs/妊娠期高血压疾病/多聚嘧啶区结合蛋白质/妊娠结局/子痫前期/miR-384

Key words

MicroRNA/Hypertensive disorder complicating pregnancy/Polypyrimidine tract-binding protein/Pregnancy outcome/Pre-eclampsia/miR-384

引用本文复制引用

基金项目

河北省卫生健康委科研基金项目(20210598)

出版年

2024
临床和实验医学杂志
首都医科大学附属北京友谊医院

临床和实验医学杂志

CSTPCD
影响因子:1.504
ISSN:1671-4695
段落导航相关论文